SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who wrote ()2/7/2000 7:47:00 PM
From: Street Walker  Read Replies (1) of 5582
 
GUMM comparison to KIDE

Last year KIDE was in the same spot as GUMM. It had been dishing out negative earnings, then it released its first profitable quarter. It jumped up and then sold off like GUMM has done in the last few days. Then growth value buyers came in, but there were few shares for the institutions to buy. So KIDE announced a stock split. Shorts covered in droves and moved it to $40 where it split. The buying at $20 rushed it up to $40 again within just a few weeks and another split was announced. Growth Value Buyers, imho, are getting ready to buy now that the stock has sold off from $36 retracement.

Regards,
S.W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext